NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Secured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Secured Loans | ₹25 Cr | ₹0.75 Cr | ₹2.07 Cr | ₹3.44 Cr | ₹6.13 Cr |
What is the latest Secured Loans ratio of NGL FINECHEM ?
| Year | Secured Loans |
|---|---|
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹0.75 Cr |
| Mar2023 | ₹2.07 Cr |
| Mar2022 | ₹3.44 Cr |
| Mar2021 | ₹6.13 Cr |
How is Secured Loans of NGL FINECHEM Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹25 Cr | 3,300.81 | |
| Mar2024 | ₹0.75 Cr | -64.06 | |
| Mar2023 | ₹2.07 Cr | -39.67 | |
| Mar2022 | ₹3.44 Cr | -43.96 | |
| Mar2021 | ₹6.13 Cr | - | |
Compare Secured Loans of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹923.1 Cr | -1.1% | 2.2% | -28% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,791.0 Cr | 1.2% | 4.2% | -10.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,885.0 Cr | -0.5% | 8.9% | 10.8% | Stock Analytics | |
| CIPLA | ₹127,930.0 Cr | 0.4% | 3.7% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,108.0 Cr | -0% | -2.1% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,164.0 Cr | 2.2% | -1.8% | -4.4% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -1.1% |
2.2% |
-28% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses